These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1387365)

  • 1. Selective screening on hormonedependent tumours of women's reproductive system organs.
    Kuznesov VV
    Eur J Gynaecol Oncol; 1992; 13(1 Suppl):65-8. PubMed ID: 1387365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective screening of hormonodependent tumours in women's reproductive system organs.
    Kuznetzov VV; Semiglazov VF; Maximov SYa
    Eur J Gynaecol Oncol; 1993; 14(2):95-8. PubMed ID: 8500503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic peculiarities of endometrial and cervical cancer incidence in five continents (review).
    Tkeshelashvili VT; Bokhman JV; Kuznetzov VV; Maximov SJ; Chkuaseli GT
    Eur J Gynaecol Oncol; 1993; 14(2):89-94. PubMed ID: 8500502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cross-sectional epidemiological research on genital and breast cancers in the North-East region of Romania].
    Matei M; Olteanu S; Ciolpan C; Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):775-85. PubMed ID: 20201268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on cancer control in women.
    Boyle P; Maisonneuve P; Autier P
    Int J Gynaecol Obstet; 2000 Aug; 70(2):263-303. PubMed ID: 10960611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic cancers.
    Blair AR; Casas CM
    Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic analysis of breast and gynecologic cancers.
    Hulka BS
    Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and female malignancies.
    Benedetto C; Salvagno F; Canuto EM; Gennarelli G
    Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):528-40. PubMed ID: 25779915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for the major malignancies affecting women: current guidelines.
    Paley PJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):1021-30. PubMed ID: 11303215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of the gynecological and mammary cancer to the HOMEL and in the CUGO Cotonou, Bénin].
    Tonato Bagnan JA; Denakpo JL; Aguida B; Hounkpatin L; Lokossou A; De Souza J; Perrin RX
    Bull Cancer; 2013 Feb; 100(2):141-6. PubMed ID: 23449498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study.
    Kato I; Zeleniuch-Jacquotte A; Toniolo PG; Akhmedkhanov A; Koenig K; Shore RE
    J Public Health Med; 2000 Jun; 22(2):155-60. PubMed ID: 10912553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
    Jalil NA; Zin AA; Othman NH
    Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polycystic ovary syndrome and gynecological cancer risk.
    Meczekalski B; Pérez-Roncero GR; López-Baena MT; Chedraui P; Pérez-López FR
    Gynecol Endocrinol; 2020 Apr; 36(4):289-293. PubMed ID: 32103691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of gynaecologic and breast cancers].
    Grzybowski W; Powolny M; Pietrzak P; Szafranko K
    Ginekol Pol; 2001 Dec; 72(12A):1465-72. PubMed ID: 11883298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003.
    Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK
    Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histo-epidemiological aspects of gynecological and breast cancers at the University Teaching Hospital of Yaoundé.
    Kemo ADD; Nkegoum B; Nangue C; Djuikwo F; Bita'a LB; Tebeu PM
    Pan Afr Med J; 2019; 33():130. PubMed ID: 31558929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer risk in women: a possible connection with geographic and certain economic and social factors].
    Borisenkov MF; Anisimov VN
    Vopr Onkol; 2011; 57(3):343-54. PubMed ID: 21882606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass screening of gynecological cancers in public health].
    Solignac M
    Presse Med; 2003 Jan; 32(2):88-91. PubMed ID: 12653035
    [No Abstract]   [Full Text] [Related]  

  • 20. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.